Acutaas Chemicals · NSE: ACUTAAS · BSE: 543349
Q3 FY26 results · Oct–Dec 2025
Acutaas Chemicals reported revenue from operations of ₹393.18 crore (up 43.0% from Q3 FY25) and net profit of ₹106.22 crore (up 133.7% from Q3 FY25) for Q3 FY26 (Oct–Dec 2025), on a consolidated basis.
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 393.18 | 274.99 | +43.0% | 306.20 | +28.4% |
| Other income | 4.70 | 1.67 | +181.2% | 9.84 | −52.2% |
| Total income | 397.88 | 276.66 | +43.8% | 316.03 | +25.9% |
| Profit before tax | 144.67 | 63.33 | +128.4% | 96.18 | +50.4% |
| Net profit for the period | 106.22 | 45.45 | +133.7% | 71.86 | +47.8% |
| Attributable to shareholders of the company | 107.96 | 44.95 | +140.2% | 72.24 | +49.4% |
| EPS, basic (₹) | 13.19 | 11.35 | not comparable | 8.82 | +49.5% |
| Net margin (%) | 27.0 | 16.5 | 23.5 |
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 390.86 | 270.94 | +44.3% | 305.19 | +28.1% |
| Other income | 6.34 | 2.17 | +192.8% | 8.97 | −29.3% |
| Total income | 397.20 | 273.11 | +45.4% | 314.16 | +26.4% |
| Profit before tax | 150.70 | 62.54 | +141.0% | 97.28 | +54.9% |
| Net profit for the period | 111.57 | 45.31 | +146.3% | 72.89 | +53.1% |
| EPS, basic (₹) | 13.63 | 11.31 | not comparable | 8.90 | +53.1% |
| Net margin (%) | 28.5 | 16.7 | 23.9 |
Consolidated
- Filed with BSE
- 28 Jan 2026, 18:08 IST
- Board meeting
- 28 Jan 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 28 Jan 2026, 18:08 IST
- Board meeting
- 28 Jan 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE